• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-030
Medical Device Problem Code Unintended Movement (3026)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 12/04/2018
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2018, a 30mm amplatzer atrial septal occluder (aso) was selected for use.The 30mm aso was deployed and released at the defect, but embolized into the right atrium.The 30mm aso was retrieved and a 28mm amplatzer atrial septal occluder was implanted.Per user, improper initial placement attributed to the event of embolization.The patient did not experience any adverse consequences and is stable.
 
Additional Manufacturer Narrative
An event of embolization was reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.Based on the information received, the cause of the embolization could not be conclusively determined; however, information from the field indicated that per the user, improper placement attributed to the event.
 
Event or Problem Description
On (b)(6) 2018, a 30mm amplatzer atrial septal occluder (aso) was selected for use.The 30mm aso was deployed and released at the defect, but embolized into the right atrium.The 30mm aso was retrieved and a 28mm amplatzer atrial septal occluder was implanted.Per user, improper initial placement attributed to the event of embolization.The patient did not experience any adverse consequences and is stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key8196774
Report Number2135147-2018-00254
Device Sequence Number1721441
Product Code MLV
UDI-Device Identifier05415067019332
UDI-Public05415067019332
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P000039
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/30/2020
Device Model Number9-ASD-030
Device Catalogue Number9-ASD-030
Device Lot Number5318766
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 12/04/2018
Supplement Date Received by Manufacturer06/11/2019
Initial Report FDA Received Date12/26/2018
Supplement Report FDA Received Date06/12/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age51 YR
-
-